Shares of Vir Biotechnology (NASDAQ: VIR) were sinking 18.1% for the week as of the market close on Thursday. Vir was pulled down by the overall stock market sell-off earlier this week. It's best to avoid making investment decisions based on analysts' downgrades (and upgrades, for that matter).
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting